| abstract |
According to the present invention, after extracting lipopolysaccharide (LPS) that induces an inflammatory response, the hyangbuja extract is treated with interleukin ((interleukin) -1β, IL-1β, IL-6, IL-8) and tumor necrosis factor by an immune response. ((tumor necrosis factor) -α, TNF-α), NO inhibitory activity and COX-2, iNOS is shown to be an excellent inhibitory effect can be used as a skin external pharmaceutical composition or cosmetic composition for the treatment and prevention of inflammatory diseases have. |